Proteasome Inhibition as a Novel Therapeutic Approach in the Management of Non-Hodgkin's Lymphoma

Following this activity, participants should be able to:

*Describe the role of the proteasome in health and disease

*Summarize the new proteasome inhibitors and their mode of action

*Describe clinical use of proteasome inhibitors

Faculty:

Andrew D Zelenetz, MD, PhD

Memorial Sloan-Kettering Cancer Center

A presentation from the NCCN 10th Annual Conference:

Clinical Practice Guidelines & Outcome Data in Oncology held in Hollywood, Florida on March 19th 2005

Release date: June 30, 2005

Expiration date: July 1, 2006

It is brand new and still factory sealed.

I will ship internationally.

Shipping within the US is free. I will combine shipping for international orders.